Rankings
▼
Calendar
TKNO Q1 2020 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$135M
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$6M
Gross Profit
$4M
59.4% margin
Operating Income
$1M
16.6% margin
Net Income
$948,000
15.5% margin
EPS (Diluted)
$0.01
Cash Flow
Operating Cash Flow
-$82,000
Free Cash Flow
-$441,000
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
-$49M
Stockholders' Equity
$49M
Cash & Equivalents
-$10M
← FY 2020
All Quarters
Q2 2020 →